Status:
RECRUITING
Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Familial Mediterranean Fever
MEFV Gene Mutation
Eligibility:
All Genders
4+ years
Brief Summary
Familial Mediterranean fever (FMF) is the most common auto-inflammatory disease (prevalence: 1-5 / 10,000 inhabitants). It is caused by mutations in the MEFV gene, which encodes variants of the Pyrine...
Eligibility Criteria
Inclusion
- Children 4 years of age or older or adults
- Having a clinical picture compatible with an FMF and a previous genetic analysis finding at least one mutation of the MEFV gene pathogenic or possibly pathogenic for the FMF group;
- Newly diagnosed or in the process of follow-up (with no time limit or evolutionary criteria);
- During specific or non-specific treatment of the disease or without treatment;
- For whom a blood test is planned as part of routine care;
- Whose informed non-opposition has been collected (or parental non-opposition in the case of a minor patient);
Exclusion
- Person under legal protection or under the protection of justice or any other protective measures;
- Person out of state to express their consent;
- Person in emergency situation, vital or not;
- Known infections with HIV and / or HBV and / or HCV;
Key Trial Info
Start Date :
July 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2029
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04478409
Start Date
July 21 2021
End Date
July 1 2029
Last Update
July 19 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Femme-Mère-Enfant
Bron, France, 69677
2
CH de Versailles - Hôpital André Mignot
Le Chesnay, France, 78157
3
Hôpital Edouard Herriot
Lyon, France, 69008
4
Hôpital de la Croix-Rousse
Lyon, France, 69317